Home > Insider Trading > Filing (0001567619-21-002063)

Filing Details

Accession Number:: 0001567619-21-002063
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-03 09:01:13
Reporting Period:: 2021-02-02

Accepted Time:: 2021-02-03 09:01:13
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1628171	Revolution Medicines Inc.	RVMD	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1246842	A Mark Goldsmith	C/O Revolution Medicines, Inc. 700 Saginaw Drive Redwood City CA 94063	See Remarks	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-02-02	5,000	$1.12	5,744	No	4	M	Direct
Common Stock	Disposition	2021-02-02	4,200	$45.26	1,544	No	4	S	Direct
Common Stock	Disposition	2021-02-02	800	$46.26	744	No	4	S	Direct
Common Stock	Disposition	2020-12-18	246,604	$0.00	247,093	No	5	G	Indirect	Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	5	G	Indirect	Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2021-02-02	5,000	$0.00	5,000	$1.12

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
78,486		2028-04-19	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	35,953	Indirect	Trust
Common Stock	35,953	Indirect	Trust

Footnotes

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
Includes 744 shares acquired under the Issuer's Employee Stock Purchase Plan on November 30, 2020.
The transaction was executed in multiple trades in prices ranging from $45.00 to $45.96, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The transaction was executed in multiple trades in prices ranging from $46.04 to $46.32, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
On December 2, 2020, Third Rock Ventures GP III, L.P. distributed 27 shares to the Goldsmith Children 2011 Irrevocable Education Trust through an in-kind, pro rata distribution without value. This distribution was exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9.
Held by Jonathan Henry Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
Held by Rebecca Eve Goldsmith Trust under the Goldsmith Children's 2011 Irrevocable Education Trust, dated December 15, 2011.
This transaction involved a gift of securities by the Reporting Person.
On December 2, 2020, Third Rock Ventures GP III, L.P. distributed 245 shares to the Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust through an in-kind, pro rata distribution without value. This distribution was exempt from Section 16 of the Exchange Act pursuant to Rule 16a-9.
Held by Mark A. Goldsmith and Anne E. Midler 2002 Revocable Living Trust.
This option is early exercisable. One forty-eighth (1/48th) of the shares subject to the option will vest on each monthly anniversary measured from March 29, 2018 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date.